These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 27454027)
1. Evolution of novel therapeutic options for pancreatic cancer. Saluja AK; Dudeja V; Banerjee S Curr Opin Gastroenterol; 2016 Sep; 32(5):401-407. PubMed ID: 27454027 [TBL] [Abstract][Full Text] [Related]
2. Overview of resistance to systemic therapy in patients with breast cancer. Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229 [TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. Targeted Therapies for Pancreatic Cancer and Hurdles Ahead. Aslan M; Shahbazi R; Ulubayram K; Ozpolat B Anticancer Res; 2018 Dec; 38(12):6591-6606. PubMed ID: 30504367 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies. Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797 [TBL] [Abstract][Full Text] [Related]
7. Patterns of failure following surgical resection for malignant pleural mesothelioma. Jänne PA; Baldini EH Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064 [TBL] [Abstract][Full Text] [Related]
8. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma. Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874 [TBL] [Abstract][Full Text] [Related]
9. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography. Mortensen MB Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296 [TBL] [Abstract][Full Text] [Related]
10. Current Perspectives on Novel Drug Carrier Systems and Therapies for Management of Pancreatic Cancer: An Updated Inclusive Review. Bhosale RR; Gangadharappa HV; Gowda DV; Osmani RAMA; Vaghela R; Kulkarni PK; Sairam KV; Gurupadayya B Crit Rev Ther Drug Carrier Syst; 2018; 35(3):195-292. PubMed ID: 29953347 [TBL] [Abstract][Full Text] [Related]
11. A review of systemic therapy for advanced pancreatic cancer. El-Rayes BF; Philip PA Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer: Stroma and its current and emerging targeted therapies. Kota J; Hancock J; Kwon J; Korc M Cancer Lett; 2017 Apr; 391():38-49. PubMed ID: 28093284 [TBL] [Abstract][Full Text] [Related]
13. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415. Adis International Ltd Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590 [TBL] [Abstract][Full Text] [Related]
14. Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies. Teague A; Lim KH; Wang-Gillam A Ther Adv Med Oncol; 2015 Mar; 7(2):68-84. PubMed ID: 25755680 [TBL] [Abstract][Full Text] [Related]
15. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts. Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495 [TBL] [Abstract][Full Text] [Related]